ILCA School 2026

Learning

3-4 December | Buenos Aires, Argentina

ILCA School of Liver Cancer comes to Latin America

The ILCA School of Liver Cancer is a unique multidisciplinary and interactive educational platform for practitioners and investigators to learn about the principles and nuances of the diagnosis, management, and clinical investigation of liver cancer.

Delivered over 1.5 intensive days by world-leading specialists, this landmark edition brings high-level medical education and collaborative learning to Latin America for the very first time.

Dates: 3–4 December 2026

Venue: Austral University Hospital | Buenos Aires, Argentina

Format: 1.5-Day Intensive Educational Course

Registrations will open soon!

Download the full programme

Learning

Key Learnings from ILCA School 2025

Overall, the School successfully delivered high-impact, practice-oriented education, blending international expertise with Indian clinical perspectives, and fostered meaningful academic exchange among hepatologists, oncologists, surgeons, interventional radiologists, and trainees.

Relive the Programme

Indian ground realities: Rising burden of HCC and CCA, MASLD-driven HCC, viral hepatitis–related oncogenesis, and challenges in surveillance penetration.

Biology to bedside: Tumor microenvironment, molecular sub-typing of CCA, liquid biopsy, and translational biomarkers.

Detection & staging: LI-RADS utility, AMRI and biomarker panels, and practical staging algorithms for routine clinical use.

Curative and locoregional approaches: Resection eligibility, transplant criteria, downstaging/bridging strategies, SBRT, and evolving LRT techniques.

Systemic therapy landscape: First-line and beyond-first-line immunotherapy and targeted therapy, dual-checkpoint strategies, toxicity management in cirrhotic patients, and late-phase trial updates.

Cholangiocarcinoma focus: Dedicated sessions on diagnosis, staging, surgery, locoregional therapy, and precision systemic treatments.

Multidisciplinary integration: Tumor boards, management of portal hypertension in HCC, and real-world decision-making dilemmas.

Interactive case panels: PVTT, intermediate HCC with combination therapy, oligometastatic disease, and challenging CCA scenarios, encouraging audience participation and voting.

2024

Look Back at ILCA School

Relive the Best Moments

Watch all the Pictures

Programme

Thanks to the collaborative support of the Korean Association of Liver Cancer, we were thrilled to host the 2024 edition of the ILCA School of Liver Cancer in Seoul.

The ILCA School was a unique learning platform for practitioners and investigators to receive education in an intense, interactive, and multidisciplinary format. This one-day ILCA School covered the latest developments in liver cancer research and treatment, including updates on tumour biology, clinical trial advances, and expert insights on management strategies. Additionally, we helped to enhance your research tools, such as oral presentation and statistical interpretation skills. It was a productive and engaging meeting!

We extend our heartfelt thanks to everyone who attended the 2024 edition.

Grant

The ILCA School of Liver Cancer 2024 was supported by an unrestricted educational grant from Bayer

Search

How Can We Help?